Frizzleds are dynamic, molecular machines
Maria Kowalski-Jahn and Hannes Schihada, two postdocs in the Schulte laboratory, have used a novel technology of fluorescently labelling receptors with a minimally invasive technique and detecting structural rearrangements in a receptor molecule in living cells. These experiments pinpointed how FZDs respond to WNT stimulation by conformational changes in the extracellular domain of the receptor.
Cell surface receptors are essential to transmit information from the outside of the cell to the inside to accomplish a physiological adaptation in response to the perceived signal. This basic concept of cellular communication can be exploited by therapeutic intervention using drugs that either mimic the bodily molecule activating the receptor (agonists) or interfere with binding of the bodily molecule as so-called antagonists. Irrespectively, the dynamic process of receptor activation can only be targeted if it is understood in its basic details. The Schulte laboratory works on Class F G protein-coupled receptors including Frizzleds, which are seen as attractive drug targets for example for cancer therapy. So far, however, the molecular underpinnings of ligand (WNT)-induced FZD activation remains obscure.
Maria Kowalski-Jahn and Hannes Schihada, two postdocs in the Schulte laboratory, have used a novel technology of fluorescently labelling receptors with a minimally invasive technique and detecting structural rearrangements in a receptor molecule in living cells. These experiments pinpointed how FZDs respond to WNT stimulation by conformational changes in the extracellular domain of the receptor. In contrast to what was previously surmised, but in line with several previous publications by the Schulte laboratory, these findings underline that WNT stimulation elicits conformational rearrangements in their receptors. These new insights into FZD dynamics present the basis for a continued mechanism-based drug discovery process to target FZDs for therapy.
This work was done in collaboration with Thomas P Sakmar and Thomas Huber from the Rockefeller University, New York, USA and funded by the Swedish Research Council, the Swedish Cancer Society, novonordiskfonden, the German Research Foundation (DFG), Wenner-Gren Foundations, and the Swedish National Infrastructure for Computing (SNIC), National Supercomputer Centre (NSC) in Linköping and KTH Royal Institute of Technology (PDC) in Stockholm.
Read the publication here: